CORRECTION: Ethiopia/AstraZeneca breast cancer project

In our report on the five-year breast cancer program organized by the Anglo-Swedish drug major AstraZeneca, the Ethiopian Ministry of Health and health care access campaign group Axios (Marketletter March 17), we incorrectly stated that "five-year findings" from the program had been published in the journal Clinical Oncology. In fact, the program was launched in 2005 and has reported on its first three years of operation at the Tikur Anbessa University. We are pleased to set the record straight and apologize for our error.